ALXO financials
ALX Oncology (ALXO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ALXO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$104.02M | -$101.69M | -1.90 |
| 2024 | – | – | -$142.47M | -$134.85M | -2.58 |
| 2023 | – | – | -$170.28M | -$160.81M | -3.74 |
| 2022 | $0.00 | – | -$127.44M | -$123.48M | -3.03 |
| 2021 | $0.00 | – | -$83.56M | -$83.46M | -2.07 |
| 2020 | $1.18M | – | -$43.66M | -$50.94M | -2.76 |